Prothena Corp Public (PRTA) Free Cash Flow Growth (5y) (2017 - 2026)
Prothena Corp Public (PRTA) Free Cash Flow Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.11 Bn | 463.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.48 Bn | 115.23 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.55 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 55.66 Bn | 50.47 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.42 Bn | 34.41 Bn | 959.66 Mn |
| 10 | Prothena Corp Public | 465.92 Mn | 136.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.36% |
| Dec 31, 2025 | -4.02% |
| Sep 30, 2025 | -15.81% |
| Jun 30, 2025 | -19.89% |
| Mar 31, 2025 | -18.16% |
| Dec 31, 2024 | -26.79% |
| Sep 30, 2024 | -37.51% |
| Jun 30, 2024 | 26.97% |
| Mar 31, 2024 | -33.02% |
| Dec 31, 2023 | -18.41% |
| Sep 30, 2023 | 17.81% |
| Jun 30, 2023 | -22.76% |
| Mar 31, 2023 | -8.38% |
| Dec 31, 2022 | 33.66% |
| Sep 30, 2022 | -11.36% |
| Jun 30, 2022 | 0.48% |
| Mar 31, 2022 | 1.48% |
| Dec 31, 2021 | 11.07% |
| Sep 30, 2021 | 37.40% |
| Jun 30, 2021 | 27.02% |